Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.40 per share
-
Shares outstanding
-
23.6M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
13.4M
-
Shares change
-
+1.56M
-
Total reported value, excl. options
-
$167M
-
Value change
-
+$17.5M
-
Number of buys
-
22
-
Number of sells
-
-19
-
Price
-
$12.42
Significant Holders of Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share (AUTL) as of Q3 2019
51 filings reported holding AUTL - Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share as of Q3 2019.
Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share (AUTL) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.4M shares
of 23.6M outstanding shares and own 56.93% of the company stock.
Largest 10 shareholders include Woodford Investment Management Ltd (2.1M shares), Capital World Investors (1.7M shares), MILLENNIUM MANAGEMENT LLC (1.4M shares), Polygon Management Ltd. (1.3M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.15M shares), JUPITER ASSET MANAGEMENT LTD (705K shares), Alphabet Inc. (699K shares), Capital International Investors (675K shares), MARSHALL WACE, LLP (507K shares), and Artal Group S.A. (500K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.